Rank;Global Rank;Institution;Country;Sector
1;29;Nokia, Finland;FIN;Companies
2;38;Ericsson Sweden;SWE;Companies
3;42;Hoffmann-La Roche, GmbH., Germany;DEU;Companies
4;69;Novartis Institutes for Biomedical Research, Switzerland;CHE;Companies
5;81;Nokia, Germany *;DEU;Companies
6;106;Microsoft, United Kingdom;GBR;Companies
7;114;Philips Research, Eindhoven;NLD;Companies
8;130;Microsoft Research Cambridge, UK;GBR;Companies
9;138;Hoffmann-La Roche Ltd, Switzerland;CHE;Companies
10;149;Bosch, Germany;DEU;Companies
11;163;IBM Switzerland;CHE;Companies
12;185;AstraZeneca, United Kingdom;GBR;Companies
13;195;Siemens AG, Germany;DEU;Companies
14;217;AstraZeneca, Sweden;SWE;Companies
15;236;France Telecom, S.A.;FRA;Companies
16;239;Carl Zeiss AG;DEU;Companies
17;252;Siemens Healthineers, Germany;DEU;Companies
18;255;Merck KGaA, Germany;DEU;Companies
19;270;Pfizer Inc, Spain Granada;ESP;Companies
20;274;Janssen Research & Development, LLC;BEL;Companies
21;276;Boehringer Ingelheim GmbH Germany;DEU;Companies
22;284;Sanofi, France;FRA;Companies
23;289;Bayer AG, Germany;DEU;Companies
24;302;Sanofi Pasteur MSD, France;FRA;Companies
25;308;Nokia Bell Labs, France;FRA;Companies
26;311;Novo Nordisk A/S;DNK;Companies
27;319;UCB Pharma SA, Belgium;BEL;Companies
28;321;Danone Nederland BV;NLD;Companies
29;345;BASF, Germany;DEU;Companies
30;346;GlaxoSmithKline, United Kingdom;GBR;Companies
31;363;Nokia, France;FRA;Companies
32;379;Infineon Technologies Austria AG;AUT;Companies
33;384;IMEC International;BEL;Companies
34;387;Novartis, Switzerland;CHE;Companies
35;399;Nestle Switzerland;CHE;Companies
36;415;BMW AG, Germany;DEU;Companies
37;476;Thales Group France, S.A.;FRA;Companies
38;521;Volkswagen AG, Germany;DEU;Companies
39;638;STMicroelectronics, France;FRA;Companies
40;662;STMicroelectronics, Italy;ITA;Companies
41;695;Sanofi, Germany;DEU;Companies
42;744;Unilever, United Kingdom;GBR;Companies
43;768;Syngenta, United Kingdom;GBR;Companies
44;843;Pfizer Inc, United Kingdom;GBR;Companies
45;863;VTT Technical Research Centre of Finland;FIN;Companies
46;956;GlaxoSmithKline, Belgium;BEL;Companies
47;1000;Airbus, Germany;DEU;Companies
48;1003;Renault SAS, France;FRA;Companies
49;1032;Bruker Corp;DEU;Companies
50;1114;AUDI AG, Germany;DEU;Companies
51;1258;Infineon Technologies Germany;DEU;Companies
52;1783;Hypertension Arterielle, Pulmonaire: Physiopathologie et Innovation Therapeutique;FRA;Companies
53;2124;Airbus, France;FRA;Companies
54;2370;Equinor ASA, Norway;NOR;Companies
55;2404;Shell, Netherlands;NLD;Companies
56;2609;TotalEnergies, France;FRA;Companies
57;2898;European XFEL GmbH;DEU;Companies
58;3315;Rolls-Royce plc, United Kingdom;GBR;Companies
59;3401;Sincrotrone Trieste;ITA;Companies
60;3724;Frontiers Media SA;CHE;Companies
61;3791;SINTEF Group;NOR;Companies
62;4606;Electricite de France, S.A. *;FRA;Companies
63;7027;Atomic Weapons Establishment;GBR;Companies